FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319656543> ?p ?o ?g. }

• W4319656543 endingPage "152" @default.
• W4319656543 startingPage "141" @default.
• W4319656543 abstract "Abstract Real‐world data on the first‐line treatment of patients with advanced non‐small cell lung cancer (NSCLC) are still limited. The NEPTUN study evaluated effectiveness and safety of first‐line nab ‐paclitaxel (Abraxane) plus carboplatin ( nab ‐P/C) in patients with advanced NSCLC in routine clinical practice in Germany. Patients included in our study were aged ≥18 years, diagnosed with locally advanced or metastatic NSCLC and with decision for first‐line nab ‐P/C in routine clinical practice. Primary objective was 6‐month progression‐free survival rate (PFS6), secondary objectives included overall survival (OS), overall response rate (ORR) and safety. From 2016 to 2019, 408 patients from 75 sites were enrolled. PFS6 was 39.5% (95% CI: 34.2‐44.8), median PFS was 5.1 months (95% CI: 4.6‐5.6), ORR was 42.9% (95% CI: 37.7‐48.2). Median OS was 10.5 months (95% CI: 9.2‐11.6). In subgroup analyses, median OS for squamous vs non‐squamous histology was 11.5 months (95% CI: 9.2‐13.8) vs 9.8 months (95% CI: 8.1‐11.3) and for patients aged ≥70 vs <70 years median OS was 12.4 months (95% CI: 9.8‐15.1) vs 9.6 months (95% CI: 7.7‐11.1). Adverse events (AEs) related to nab ‐paclitaxel were reported in 247 (66.4%) patients, while carboplatin‐related AEs were documented in 224 (60.2%) patients. Most frequently related AEs were leukopenia (22.3%) for nab ‐paclitaxel and anemia (20.2%) for carboplatin. N ab ‐P/C‐related deaths were reported in 2 (0.5%) patients (sepsis and neutropenic sepsis). No new or unexpected safety signals emerged. These results support the effectiveness and safety of first‐line nab ‐P/C in patients with advanced NSCLC reported in the pivotal trial and highlight the clinical value of this regimen in the real‐world setting." @default.
• W4319656543 created "2023-02-10" @default.
• W4319656543 creator A5000222507 @default.
• W4319656543 creator A5006956385 @default.
• W4319656543 creator A5011140633 @default.
• W4319656543 creator A5026064419 @default.
• W4319656543 creator A5032121767 @default.
• W4319656543 creator A5055006530 @default.
• W4319656543 creator A5056952139 @default.
• W4319656543 creator A5057117881 @default.
• W4319656543 creator A5062182046 @default.
• W4319656543 creator A5062659492 @default.
• W4319656543 creator A5063181849 @default.
• W4319656543 creator A5064763575 @default.
• W4319656543 creator A5091422927 @default.
• W4319656543 date "2023-03-08" @default.
• W4319656543 modified "2023-09-25" @default.
• W4319656543 title "<scp>First‐line</scp><i>nab</i>‐paclitaxel plus carboplatin for patients with advanced non‐small cell lung cancer: Final results of the <scp>NEPTUN</scp> study" @default.
• W4319656543 cites W2053115929 @default.
• W4319656543 cites W2116720928 @default.
• W4319656543 cites W2149564448 @default.
• W4319656543 cites W2164067249 @default.
• W4319656543 cites W2508069933 @default.
• W4319656543 cites W2527905628 @default.
• W4319656543 cites W2604685477 @default.
• W4319656543 cites W2770609569 @default.
• W4319656543 cites W2796582438 @default.
• W4319656543 cites W2806388842 @default.
• W4319656543 cites W2810038734 @default.
• W4319656543 cites W2888194612 @default.
• W4319656543 cites W2892640821 @default.
• W4319656543 cites W2898311727 @default.
• W4319656543 cites W2946386783 @default.
• W4319656543 cites W3003499321 @default.
• W4319656543 cites W3017322331 @default.
• W4319656543 cites W3121907365 @default.
• W4319656543 cites W3135105663 @default.
• W4319656543 cites W3154805493 @default.
• W4319656543 cites W4210992155 @default.
• W4319656543 cites W4251472767 @default.
• W4319656543 doi "https://doi.org/10.1002/ijc.34467" @default.
• W4319656543 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36757197" @default.
• W4319656543 hasPublicationYear "2023" @default.
• W4319656543 type Work @default.
• W4319656543 citedByCount "1" @default.
• W4319656543 countsByYear W43196565432023 @default.
• W4319656543 crossrefType "journal-article" @default.
• W4319656543 hasAuthorship W4319656543A5000222507 @default.
• W4319656543 hasAuthorship W4319656543A5006956385 @default.
• W4319656543 hasAuthorship W4319656543A5011140633 @default.
• W4319656543 hasAuthorship W4319656543A5026064419 @default.
• W4319656543 hasAuthorship W4319656543A5032121767 @default.
• W4319656543 hasAuthorship W4319656543A5055006530 @default.
• W4319656543 hasAuthorship W4319656543A5056952139 @default.
• W4319656543 hasAuthorship W4319656543A5057117881 @default.
• W4319656543 hasAuthorship W4319656543A5062182046 @default.
• W4319656543 hasAuthorship W4319656543A5062659492 @default.
• W4319656543 hasAuthorship W4319656543A5063181849 @default.
• W4319656543 hasAuthorship W4319656543A5064763575 @default.
• W4319656543 hasAuthorship W4319656543A5091422927 @default.
• W4319656543 hasBestOaLocation W43196565431 @default.
• W4319656543 hasConcept C126322002 @default.
• W4319656543 hasConcept C143998085 @default.
• W4319656543 hasConcept C197934379 @default.
• W4319656543 hasConcept C2776256026 @default.
• W4319656543 hasConcept C2776694085 @default.
• W4319656543 hasConcept C2777292972 @default.
• W4319656543 hasConcept C2778239845 @default.
• W4319656543 hasConcept C2780873365 @default.
• W4319656543 hasConcept C2781451048 @default.
• W4319656543 hasConcept C71924100 @default.
• W4319656543 hasConcept C90924648 @default.
• W4319656543 hasConceptScore W4319656543C126322002 @default.
• W4319656543 hasConceptScore W4319656543C143998085 @default.
• W4319656543 hasConceptScore W4319656543C197934379 @default.
• W4319656543 hasConceptScore W4319656543C2776256026 @default.
• W4319656543 hasConceptScore W4319656543C2776694085 @default.
• W4319656543 hasConceptScore W4319656543C2777292972 @default.
• W4319656543 hasConceptScore W4319656543C2778239845 @default.
• W4319656543 hasConceptScore W4319656543C2780873365 @default.
• W4319656543 hasConceptScore W4319656543C2781451048 @default.
• W4319656543 hasConceptScore W4319656543C71924100 @default.
• W4319656543 hasConceptScore W4319656543C90924648 @default.
• W4319656543 hasIssue "1" @default.
• W4319656543 hasLocation W43196565431 @default.
• W4319656543 hasLocation W43196565432 @default.
• W4319656543 hasOpenAccess W4319656543 @default.
• W4319656543 hasPrimaryLocation W43196565431 @default.
• W4319656543 hasRelatedWork W1502181122 @default.
• W4319656543 hasRelatedWork W1567229547 @default.
• W4319656543 hasRelatedWork W2053778437 @default.
• W4319656543 hasRelatedWork W2055244776 @default.
• W4319656543 hasRelatedWork W2311734504 @default.
• W4319656543 hasRelatedWork W2320097775 @default.
• W4319656543 hasRelatedWork W2350189833 @default.
• W4319656543 hasRelatedWork W2428731653 @default.
• W4319656543 hasRelatedWork W2884909153 @default.
• W4319656543 hasRelatedWork W2526994713 @default.

• next